A meta-analysis of anticoagulation for calf deep venous thrombosis

Randall R De Martino, Jessica B. Wallaert, Ana P. Rossi, Alicia J. Zbehlik, Bjoern Suckow, Daniel B. Walsh

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Objective: This meta-analysis was initiated to assess the efficacy and safety of anticoagulation therapy for adult patients with isolated calf vein deep venous thrombosis (DVT). Methods: We searched MEDLINE (1950-October 2010), the Cochrane Library (1993-October 2010), trial registries, meeting abstracts, and selected references, using no limits. Included studies compared the results of anticoagulation (vitamin K antagonist or therapeutic heparin) for a minimum of 30 days vs the results of no anticoagulation in adults with calf vein DVT proved by ultrasound imaging or venograph who were monitored for at least 30 days. Two independent reviewers extracted data using a piloted standardized form. Methodologic quality was assessed using the Cochrane Risk of Bias tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Quality Assessment Scale for cohort and case-control studies. Discrepancies were resolved by consensus or by a third reviewer. Authors were contacted for additional information if necessary. Outcomes were pooled using Peto fixed-effects models. Results: Of 2328 studies identified, two RCTs and six cohorts (126 patients treated with anticoagulation and 328 controls) met selection criteria. The methodologic quality of most studies was poor. Pulmonary embolism (PE; odds ratio, 0.12; 95% confidence interval, 0.02-0.77; P =.03) and thrombus propagation (odds ratio, 0.29; 95% confidence interval, 0.14-0.62; P =.04) were significantly less frequent in those who received anticoagulation. Significant heterogeneity existed in studies reporting mortality rates, but these demonstrated a trend toward fewer deaths with anticoagulation. When limited to randomized trials, the protective effect of anticoagulation for PE was no longer statistically significant, but the benefit for preventing thrombus progression persisted. Adverse events such as bleeding were sparsely reported but favored controls (P =.65). Conclusions: Our review suggests that anticoagulation therapy for calf vein DVT may decrease the incidence of PE and thrombus propagation. However, due to poor methodologic quality and few events among included studies for PE, this finding is not robust. Thrombus propagation appears reduced with anticoagulation treatment. A rigorous RCT will assist in treatment decisions for calf vein DVT.

Original languageEnglish (US)
Pages (from-to)228-236
Number of pages9
JournalJournal of Vascular Surgery
Volume56
Issue number1
DOIs
StatePublished - Jul 2012
Externally publishedYes

Fingerprint

Venous Thrombosis
Meta-Analysis
Veins
Thrombosis
Randomized Controlled Trials
Odds Ratio
Confidence Intervals
Therapeutics
Vitamin K
Pulmonary Embolism
MEDLINE
Patient Selection
Libraries
Registries
Heparin
Case-Control Studies
Ultrasonography
Hemorrhage
Safety
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

De Martino, R. R., Wallaert, J. B., Rossi, A. P., Zbehlik, A. J., Suckow, B., & Walsh, D. B. (2012). A meta-analysis of anticoagulation for calf deep venous thrombosis. Journal of Vascular Surgery, 56(1), 228-236. https://doi.org/10.1016/j.jvs.2011.09.087

A meta-analysis of anticoagulation for calf deep venous thrombosis. / De Martino, Randall R; Wallaert, Jessica B.; Rossi, Ana P.; Zbehlik, Alicia J.; Suckow, Bjoern; Walsh, Daniel B.

In: Journal of Vascular Surgery, Vol. 56, No. 1, 07.2012, p. 228-236.

Research output: Contribution to journalArticle

De Martino, RR, Wallaert, JB, Rossi, AP, Zbehlik, AJ, Suckow, B & Walsh, DB 2012, 'A meta-analysis of anticoagulation for calf deep venous thrombosis', Journal of Vascular Surgery, vol. 56, no. 1, pp. 228-236. https://doi.org/10.1016/j.jvs.2011.09.087
De Martino, Randall R ; Wallaert, Jessica B. ; Rossi, Ana P. ; Zbehlik, Alicia J. ; Suckow, Bjoern ; Walsh, Daniel B. / A meta-analysis of anticoagulation for calf deep venous thrombosis. In: Journal of Vascular Surgery. 2012 ; Vol. 56, No. 1. pp. 228-236.
@article{3d62e98c2be24d1bbc7d48e3a60c78c3,
title = "A meta-analysis of anticoagulation for calf deep venous thrombosis",
abstract = "Objective: This meta-analysis was initiated to assess the efficacy and safety of anticoagulation therapy for adult patients with isolated calf vein deep venous thrombosis (DVT). Methods: We searched MEDLINE (1950-October 2010), the Cochrane Library (1993-October 2010), trial registries, meeting abstracts, and selected references, using no limits. Included studies compared the results of anticoagulation (vitamin K antagonist or therapeutic heparin) for a minimum of 30 days vs the results of no anticoagulation in adults with calf vein DVT proved by ultrasound imaging or venograph who were monitored for at least 30 days. Two independent reviewers extracted data using a piloted standardized form. Methodologic quality was assessed using the Cochrane Risk of Bias tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Quality Assessment Scale for cohort and case-control studies. Discrepancies were resolved by consensus or by a third reviewer. Authors were contacted for additional information if necessary. Outcomes were pooled using Peto fixed-effects models. Results: Of 2328 studies identified, two RCTs and six cohorts (126 patients treated with anticoagulation and 328 controls) met selection criteria. The methodologic quality of most studies was poor. Pulmonary embolism (PE; odds ratio, 0.12; 95{\%} confidence interval, 0.02-0.77; P =.03) and thrombus propagation (odds ratio, 0.29; 95{\%} confidence interval, 0.14-0.62; P =.04) were significantly less frequent in those who received anticoagulation. Significant heterogeneity existed in studies reporting mortality rates, but these demonstrated a trend toward fewer deaths with anticoagulation. When limited to randomized trials, the protective effect of anticoagulation for PE was no longer statistically significant, but the benefit for preventing thrombus progression persisted. Adverse events such as bleeding were sparsely reported but favored controls (P =.65). Conclusions: Our review suggests that anticoagulation therapy for calf vein DVT may decrease the incidence of PE and thrombus propagation. However, due to poor methodologic quality and few events among included studies for PE, this finding is not robust. Thrombus propagation appears reduced with anticoagulation treatment. A rigorous RCT will assist in treatment decisions for calf vein DVT.",
author = "{De Martino}, {Randall R} and Wallaert, {Jessica B.} and Rossi, {Ana P.} and Zbehlik, {Alicia J.} and Bjoern Suckow and Walsh, {Daniel B.}",
year = "2012",
month = "7",
doi = "10.1016/j.jvs.2011.09.087",
language = "English (US)",
volume = "56",
pages = "228--236",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - A meta-analysis of anticoagulation for calf deep venous thrombosis

AU - De Martino, Randall R

AU - Wallaert, Jessica B.

AU - Rossi, Ana P.

AU - Zbehlik, Alicia J.

AU - Suckow, Bjoern

AU - Walsh, Daniel B.

PY - 2012/7

Y1 - 2012/7

N2 - Objective: This meta-analysis was initiated to assess the efficacy and safety of anticoagulation therapy for adult patients with isolated calf vein deep venous thrombosis (DVT). Methods: We searched MEDLINE (1950-October 2010), the Cochrane Library (1993-October 2010), trial registries, meeting abstracts, and selected references, using no limits. Included studies compared the results of anticoagulation (vitamin K antagonist or therapeutic heparin) for a minimum of 30 days vs the results of no anticoagulation in adults with calf vein DVT proved by ultrasound imaging or venograph who were monitored for at least 30 days. Two independent reviewers extracted data using a piloted standardized form. Methodologic quality was assessed using the Cochrane Risk of Bias tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Quality Assessment Scale for cohort and case-control studies. Discrepancies were resolved by consensus or by a third reviewer. Authors were contacted for additional information if necessary. Outcomes were pooled using Peto fixed-effects models. Results: Of 2328 studies identified, two RCTs and six cohorts (126 patients treated with anticoagulation and 328 controls) met selection criteria. The methodologic quality of most studies was poor. Pulmonary embolism (PE; odds ratio, 0.12; 95% confidence interval, 0.02-0.77; P =.03) and thrombus propagation (odds ratio, 0.29; 95% confidence interval, 0.14-0.62; P =.04) were significantly less frequent in those who received anticoagulation. Significant heterogeneity existed in studies reporting mortality rates, but these demonstrated a trend toward fewer deaths with anticoagulation. When limited to randomized trials, the protective effect of anticoagulation for PE was no longer statistically significant, but the benefit for preventing thrombus progression persisted. Adverse events such as bleeding were sparsely reported but favored controls (P =.65). Conclusions: Our review suggests that anticoagulation therapy for calf vein DVT may decrease the incidence of PE and thrombus propagation. However, due to poor methodologic quality and few events among included studies for PE, this finding is not robust. Thrombus propagation appears reduced with anticoagulation treatment. A rigorous RCT will assist in treatment decisions for calf vein DVT.

AB - Objective: This meta-analysis was initiated to assess the efficacy and safety of anticoagulation therapy for adult patients with isolated calf vein deep venous thrombosis (DVT). Methods: We searched MEDLINE (1950-October 2010), the Cochrane Library (1993-October 2010), trial registries, meeting abstracts, and selected references, using no limits. Included studies compared the results of anticoagulation (vitamin K antagonist or therapeutic heparin) for a minimum of 30 days vs the results of no anticoagulation in adults with calf vein DVT proved by ultrasound imaging or venograph who were monitored for at least 30 days. Two independent reviewers extracted data using a piloted standardized form. Methodologic quality was assessed using the Cochrane Risk of Bias tool for randomized controlled trials (RCTs) and the Newcastle-Ottawa Quality Assessment Scale for cohort and case-control studies. Discrepancies were resolved by consensus or by a third reviewer. Authors were contacted for additional information if necessary. Outcomes were pooled using Peto fixed-effects models. Results: Of 2328 studies identified, two RCTs and six cohorts (126 patients treated with anticoagulation and 328 controls) met selection criteria. The methodologic quality of most studies was poor. Pulmonary embolism (PE; odds ratio, 0.12; 95% confidence interval, 0.02-0.77; P =.03) and thrombus propagation (odds ratio, 0.29; 95% confidence interval, 0.14-0.62; P =.04) were significantly less frequent in those who received anticoagulation. Significant heterogeneity existed in studies reporting mortality rates, but these demonstrated a trend toward fewer deaths with anticoagulation. When limited to randomized trials, the protective effect of anticoagulation for PE was no longer statistically significant, but the benefit for preventing thrombus progression persisted. Adverse events such as bleeding were sparsely reported but favored controls (P =.65). Conclusions: Our review suggests that anticoagulation therapy for calf vein DVT may decrease the incidence of PE and thrombus propagation. However, due to poor methodologic quality and few events among included studies for PE, this finding is not robust. Thrombus propagation appears reduced with anticoagulation treatment. A rigorous RCT will assist in treatment decisions for calf vein DVT.

UR - http://www.scopus.com/inward/record.url?scp=84863000732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863000732&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2011.09.087

DO - 10.1016/j.jvs.2011.09.087

M3 - Article

VL - 56

SP - 228

EP - 236

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 1

ER -